AeBeZe labs is a uniquely positioned startup that focuses on improving behavioral health by pairing proven science with powerful content. Established in 2018 and headquartered in the United States, AeBeZe is pioneering the concept of a purely digital drug company. The company's flagship product, Moodrise, is the first smartphone application to deliver on-demand Digital Nutrition, utilizing bite-sized doses of content based on peer-reviewed scientific literature. AeBeZe's innovative offerings also include Moodrise 1000, a meticulously reviewed collection of the top 1000 hours of Digitally Nutritious content, as well as Pillcast™, an auditory experience for enhanced Digital Nutrition, and wearables for mood tracking. The company's dedication to research and evidence-based products signifies its commitment to revolutionizing behavioral health. With a mission to address the critical need for mental health support, AeBeZe labs presents an opportunity for healthcare and nutrition investors to engage with a pioneering player in the digital health space. For potential investors, exploring the innovative solutions and the potential market disruption presented by AeBeZe labs could prove to be a compelling opportunity in the burgeoning digital health sector.
There is no investment information
No recent news or press coverage available for AeBeZe Labs.